For months there’ve been questions about a major source of U.S. funding for global vaccination programs. That situation may now be clearing.
The U.S. announced that it would finally provide $600 million in funds appropriated by Congress for Gavi (The Vaccine Alliance) to use for its efforts during fiscal year 2025 and FY 2026. The Alliance expressed welcome to the move on July 30th, calling the funding necessary for meeting urgent needs around access to vaccines and disease outbreak prevention and response.
This represents a development of consequence. But to NGOs working on child health, immunizations, infectious disease prevention, and community health, this development could have consequences far beyond these issue areas.
Why the $600 Million Matters
That brings us to the importance of consistent funding. Planning for vaccination efforts—ordering vaccines, campaigning to reach communities, and all the activities that enable childhood immunizations—becomes a very difficult prospect when governments and healthcare entities don’t know when—or even if—funds will be available. So when you look at the $600 million release, you’re not looking at just a dollar amount but clarity around funds that Congress has allocated.
GAVI says that funds are needed to close crucial vaccine access gaps and boost global health defenses against outbreaks. US support has always been a cornerstone of GAVI’s partnership since inception in 2000, helping to immunize more than 1.2 billion children,” a statement by GAVI read.
What Is Gavi’s Role in Global Health?
Gavi, the Vaccine Alliance, works with governments and partners to expand access to vaccines, particularly in lower-income countries.
Its work goes beyond purchasing vaccines. Gavi also supports countries in strengthening immunization systems, reaching children who have missed routine vaccinations, responding to outbreaks, and improving access to new vaccines.
The organization has set ambitious targets for its current Gavi 6.0 strategy. Its board has approved a goal of reaching 500 million children and preventing 8–9 million deaths during the strategic period.
That makes reliable donor funding particularly important.
Why This Matters for NGOs
At first glance, funding going to Gavi may seem unrelated to individual NGOs.
It isn’t.
NGOs and civil society organizations often play an important role in reaching communities that are difficult for national health systems to reach. They can support awareness campaigns, community mobilization, data collection, outreach to underserved populations, and vaccination activities.
Gavi itself has a dedicated funding mechanism for civil society organizations (CSOs) working to reach zero-dose children and communities that are being missed by routine immunization programs.
This means that stronger funding for the wider immunization system can create opportunities for NGOs involved in community-level health work.
For an NGO, the opportunity may not necessarily come as a direct grant from the U.S. government. It could come through partnerships with governments, Gavi-supported programs, local health systems, or other organizations implementing immunization activities.
Reaching the Children Who Are Still Missing Out
One of the biggest challenges in global vaccination is not simply getting vaccines available. It is making sure they reach the people who are hardest to reach.
Some children miss routine vaccinations because of poverty, conflict, displacement, weak healthcare infrastructure, geographical isolation, lack of information, or other barriers.
Gavi’s current strategy places particular attention on zero-dose children and missed communities. Its updated approach also includes additional support for fragile and humanitarian settings.
This is an area where local NGOs can be especially valuable.
A community organization may understand why families are not attending vaccination sessions, which languages should be used for awareness campaigns, or which local leaders can help build trust.
The final step of vaccination is often not about technology. It is about reaching people.
A Changing Global Health Funding Landscape
The U.S. decision also comes at a time when global health financing is changing.
Donors are facing competing priorities, governments are under financial pressure, and international health organizations are increasingly discussing how countries can become more self-reliant.
Gavi has itself emphasized a more country-led approach, with governments playing a stronger role in setting immunization priorities and gradually increasing domestic financing.
For NGOs, this could mean that future opportunities will increasingly depend on how well their programs align with national health priorities.
Organizations may need to look beyond traditional donor relationships and build stronger connections with ministries of health, local governments, healthcare providers, and other organizations working within national health systems.
What NGOs Can Learn From This Development
The $600 million announcement offers several lessons for NGOs.
First, funding stability matters. Health programs require long-term planning, and uncertainty can make it harder to maintain services.
Second, partnerships matter. NGOs should not think about funding only in terms of direct grants. Working with larger health initiatives can create opportunities to participate in wider programs.
Third, community-level knowledge has value. Organizations that can demonstrate strong relationships with underserved communities may become important partners in reaching people who are otherwise missed.
Finally, good data and accountability are essential. NGOs should be able to demonstrate who they reached, what activities they delivered, what changed, and how resources were used.
The Opportunity for Local NGOs
For smaller and local NGOs, global vaccination programs can offer an opportunity to demonstrate their value.
Large institutions may have greater financial and technical capacity, but local organizations often have something equally important: proximity to communities.
They know the local challenges and understand community concerns.
They can communicate in local languages.
And they may already have relationships with families who are difficult for larger organizations to reach.
As global health programs increasingly focus on missed communities and country-led approaches, these strengths could become more important.
Gavi’s existing CSO funding mechanism demonstrates that civil society organizations already have a role within the broader vaccination ecosystem.
What Should NGOs Do Now?
Organizations working in health and immunization can use this moment to strengthen their readiness.
They can improve their monitoring and evaluation systems, document previous health outcomes, strengthen financial management, develop partnerships with local health authorities, and clearly communicate their experience reaching underserved communities.
NGOs should also keep track of Gavi and other global health funding opportunities rather than waiting for opportunities to appear.
Gavi provides application guidance and information specifically for civil society organizations seeking funding, making it useful for eligible NGOs to understand the requirements and prepare early.
Looking Ahead
The release of $600 million to Gavi is important, but it is only one part of a much larger conversation about the future of global health funding.
The world continues to face infectious disease threats, vaccination gaps, and unequal access to healthcare. At the same time, international organizations are looking for ways to make health systems more sustainable and increasingly country-led.
For NGOs, this changing environment creates both challenges and opportunities.
Organizations that combine strong community relationships, measurable results, responsible financial management, and effective partnerships may be well positioned to contribute to future health programs.
Final Thoughts
The U.S. move to release $600 million to Gavi provides important clarity for global vaccination efforts after a period of uncertainty.
But the real impact will be measured much further down the chain—not by the announcement itself, but by whether vaccines reach children who need them.
For NGOs, that is where the opportunity lies.
Global funding can provide the resources, but local organizations can help turn those resources into real change at the community level.
As global health funding evolves, NGOs that understand their communities and can demonstrate meaningful results will remain an important part of the effort to make healthcare and vaccination accessible to everyone.
